Show UniProt / TrEMBL protein name		View in Fasta format (DNA)		View as list

# Candidatus Blochmannia floridanus

>Bfl078 amiB, N-acetylmuramoyl-L-alanine amidase
MLIFVKCLFYDVVVASSLNSISVKNNSDHSTVIIRCNAAPGYKVFLLHNP
ERMVIDLSEIIRIQNVNMFPMNFDGNNLIRHIRANVSVHCQSTRIVCDLN
YMSDIKTIIQKKVGKIYHVILMVSKKRITQSKLSTQRSYSIIDYKTCCTL
NNNKELIDNQKKIINVQYKEKVNSSGQERCPIIVAIDAGHGGHDPGATSY
YGIHEKNITFSIAKKLKKKLDSDPIFRTIMIRDGDYFLSVMARSDLARRK
KANILVSIHADSSLNSKVKGASVWILSNQRVKSEMSHWLQQCKEKYAELL
GGLGYVLTHYNIDPYFNHLILDLQFGYTQRVGYGIATHVLNQLKNVGFLH
KNIPECSGFGVLRSPDIPSILVETGFISNLQEGRLLATDKYQERIAEALY
KGLKSYFIGTQKKKLFSCT
>Bfl518 dapA, dihydrodipicolinate synthase
MFTGSIVALITPMDSKGSIDRMGLKKLVDYHVDNGTSAIVSVGTTGEMSG
LTHSEHVDVVMWTIEFSDGRLPVIAGTGSNSTSEAILLTNQFNDSAVSAC
LSVTPYYNRPSQEGLFQHFRAIAESTNLPQILYNVPIRTGCDLLPITVGR
LSTIKNIVGIKEATGNLNRVNQLKRLVNEDFILLSGDDISAVDFMRLGGH
GVISVTANVAPKDMSTLCSFVQKNDFKSAYDINNRLIPVHQSLFFDSNPI
PVKWACKELGLISYDTLRLPMTSISKEHSVLIRKALEDADLL
>Bfl474 ddlA, D-alanine:D-alanine ligase A
MKSKLRVGLVCGGCSLEHEVSLKSAIYIMKYINKRFFEVVVLWISKQGDW
YIVENDDMHIDFFVNKENLHKCMPILMFSSGNRCFEYINNILSLDVIFPI
IHGALGEDGSLQGLLRLMNLPYVGSDVLGSAICMDKDITKRLLRDSGLSI
TPFRTFLAHEKKKLKFLNFADMFGLPFFVKPVNQGSSIGVAKVNDDYSFH
SALDIAFFYSHKIIIESCIAGRELECAVLGNNENPITSVCGEIIKKNDDF
YTYCDKYVDHNSEIVIPAVLEKSVSSKIRSIAIRVFQILNCFGMARVDIF
LFGKDRIIINEVNTLPGFTSDSMYLKLWQATGINISTLLTRLIMLALDRY
YKYN
>Bfl136 ftsI, penicillin-binding protein 3 precursor
MFLNRKRLYILYGSIFFIFLFLVLRLIYLQIISSENLINSGNKRSLRIQN
ILKSRGVITDRMGRLLAVDIPVYSVWVDPQEISKCNGVYNDISSWSVISK
ILNIPIKKLFVLLNEHHTDRFVYLSRQVDSIVVQKIKKLKLSGIYIQQES
KRYYPAGSSAAHLIGITNIDNQGIEGVEKSFDSWLSGCPKTRLVRQDRSR
QVVEEIALLNHGCSPKSITLSIDERLQFVAYQELSNAVSLNKAESGSIVL
IDINTGEILAMANSPSYDPNNFSIIDQSVMRNRAITDSFEPGSTIKPIVI
MMALEHKVIEKDTIINTLPYVIHGHRIKDVSLHNELTISDILKKSSNVGI
SRLALSMPVSVLIDTYIKFGIGEMTNIGLIGENKGRIYSDIKYYSAIEHA
ALSYGYGLMLTPLQLAKVYATIGGMGLSRPISIIKIDNPVSLISSENQVF
SESLVRTVIDMMDVTTLSNSGCCKAAIEGYRVAVKTGTIKKVGPHGKYIN
RYIACMAGVAPSSNPRFALAVVINDPKNGRYYGGSVSAPVFRSVMSSALK
IMNVNPDFLQK
>Bfl144 ftsQ, cell division protein FtsQ
MQYILKLKYYLYNITWKLVFICVMLVLLIVGIHKNIKWVCDYYSGPLSYI
IVTGNRFFTTNDDINYIILKSGVLGTFITQDVNIIQKQIKQMPWIQKVSV
RKQWPNTLKINLIEYIPIAYWNNEFISTTGVVFSVSECLYNEYSSFVRKM
YQEIPILYGPTGKDQEVLNNYLRFSAILKSSNFQIKSVKTDTCYTWQLVL
DNNVCLKLGCVNLIERLHYFIKVYPFLVKEMDEKNKYIDYVDLRYNSGCS
VRWIHNMIDPVFHAINNVSKGSHDYD
>Bfl010 glmU, UDP-N-acetylglucosamine pyrophosphorylase
MLRKKYSVIILAAGQGKRMLSSIPKVMHKIAGRSMLQHLIDSVSKINIQS
IYIVYNESLREFIPTIYSNKCTISIYWVLQESVRGTGYAVQQVLSMIHDD
NEDILILYGDVPLISDKTLNNLCLMKSKCDIGLLTAYVKNPQGYGRIIRN
QYGDVVSIIEDIDIVNQNDRIIKEIHSGIFISVSGYLKSWLNYLIENNLW
CNELYLTAIIDIAYKNNFVINAIHPVDVCEVIGINNKSDLVKAERVYQIK
EAQKLLELGVMISDLNRFDLRGKLVCGEDVCIDVNVIIEGCVSLGNRVKI
GASCILKDVEIGDDVIIYPFSFIENSKIHCKSKIGPFARLRPGTCLQEQV
HIGNFVELKNIKLGNNSKVGHLSYLGDADVGNYVNIGAGTIICNYNGKTK
NYTCIEDNVFVGADSQLVAPITIGKNAVIGAGTTVTQNVDKDDVIISRVR
QFSIVNDKVDKNKKN
>Bfl280 hlpA, histone-like protein, located in outer membrane
MKNRVYMLGIIIWLAQINYVNAANKIVVMNVANIFQQSAQRTEIIKQLEY
EFKDRAAELEMMEHDLQTKMQTLQRDGATMTASDRNTLEKSLIAQRELFS
NKAKLFQQENHARQTEERDKILDMIYKIVKNIAKKENYDIVIDTNAVVYF
SSHIKDITDSVSNQMRVK
>Bfl411 htrB, lipid A biosynthesis lauroyl acyltransferase
MERLPIFKFSLLMPRFWIIWLGIAILYIIVLLPYPVIYYLGINIGRAMKY
IMLYRVQIIRKNLDLCFPHLTDSEKKTLLNKNCESMGMGIFETGMAWFWP
EYRIKRWFTINGFKHIIQAKKQKTGILLLGMHFLTLELGARILGILNPGI
GVYRPNNNPLLDWIQTKGRLKSNKKMINRTNIKSVVSALKNGEIIWYAPD
HDYGYKNSVFVPLFNVPNAASTIGTYILTKIAKPAVIPFIPRRLPKALGY
ELLIFPNKNNKISLKTRIITIQHINKLIEQIILLAPEQYMWLHRRFKTRP
PGESSFYS
>Bfl129 imp, organic solvent tolerance protein precursor
MTIYNILYKYTIHYYIIQLNKLIILNFCLNLAYINFIGIIFCYIQISHTH
DNSHKYSDHAPKLYTASDNNYNKYSNNQQHITIYAQSNNITINYPNYIQL
IGNVHIKQDNNLITSDNLTILYNQHHHSLYTSKLYAKGNVCYQNNYISIK
GSSACFDLNKKNTKIYHGAYYICKSHIYGQSSSIIHNTNNHYTIINQGKF
STCTIDNNSWNVHGSQIIYNHRKNNIDIWNACFKIKKIPIFYLPYLSFSL
NNKNILQSYIPNTRYNHKNGLILKIPFPLIFSKYYYGHISPYYLSKSGIK
LQTQIYYSHKPVGTGIINFDILQKYTKKNYNHINKSYRLHWKHDSFMHNN
WHCNIDYHFNNNHLSYFNKIKHNNMHPTYNYINQKFLFYYNNKHWKTSIT
YLGTSYSFLKNPIQKHCTYTAAPQLELHFYSSIKRPNKLINFQIFNQISR
FVPSNDFYPISTRIHTEPNITCTIKNFWGYLTAESKLHITHYQQNNTHCH
NMQTYSTSYLKHTITRIIPQFKIQGKTFFKKKSNINKKYKHFLEPKIQYL
YIPYCFQKNIGMYDTKMIYINHNTLFHGTIYSGLDRIGPNNQITTNITSR
FFKKNTETFYISLGHILNLTQRNIINYINSKKRSYFNIPNTTLLSAIVHW
NINDYWNTHSEIQYYIPTHKLFSGHSTLNFRGKKNQIFRINYRYIDSQYF
QENFTHYNKSIYCKKISQLGITTYYPLINHWTISYVQYHNTNLNHIIDQA
IGIQYFTPCWIFSIFFERKIIDWISSTQSNIYDNKIQLHLNIYNLIFNSR
QNPAKILKFNMIPYQDMV
>Bfl350 kdsA, 2-dehydro-3-deoxyphosphooctonate aldolase
MKNITVNIGNIKISNKLPFVLFGGMNVLEKYDTIMQVCEYYVSITQKLNI
PYIFKASFDKANRTSIHSYRGPGLESGLRLFQILKKKFGVKLMTDVHEIN
QAQIISEVVDVIQLPAFLARQTDLIKAIAQTGSVVNIKKPQYMSPEQVQY
IVNKFHFFKNNKIILCERGTMFGYNDLIVDILGLHKMQHVSKGCPIIVDV
THALQTRQPYSAVSEGKNRLQIFDLAKASIAVGIAGLFIEAHPDPDNAKC
DGPIALPLYQLPCFLNKIKLLDTLVKSF
>Bfl376 kdsB, 3-deoxy-manno-octulosonate cytidylyltransferase
MNFIIIIPARFFSSRFPGKLLADIQGKPMIIRVIEKALTTKTTKIIVATD
SVSIKQIVEYEYYSFGDKVEVCLTYSDHQSGTERISEIVKRYRFADDQII
VQLQGDEPLISSYMIHQIVDVFNMTTSNNISVSTLATPIFFYNEVIDSNI
VKVVVNIYGVALYFSRSMIPWMSINHDFNQELGIWLRHIGIYAYRVNFLS
RYMNWIKSSLEKYEMLEQLRILWNGETIYVSVMDNIRNISVDTPESLRKV
NELFLISN
>Bfl610 kdtA, 3-deoxy-D-manno-octulosonic-acid transferase
MFILYMFVYNIIIYSIQPIIWIRLLWRSRFVPTYRQNLGERYGFYCHKNI
KLNSIIIHAVSVGETLSVIPLIYKLRKKYPDVIITLTSMTPAGLEMAYKL
SAYYHHVQCMYLPYDLFFSVKRFLNYIQPKLVIIMETELWPNLINELYKR
RIPVIIANARLSNISFKKYKIFNRFFYYIMQRINTVAVQSKEDAFRFFSL
GFKKNRLNIVGNLKFDVSSNKINLKKILSFEKIKIEGRLVWIASSTHKGE
EIILLTVYKRLLKSFSNLLLILVPRHSERFSDVINITKHAGFSYVVRSSG
VIPTKDIQVFIVDTIGELMFLYEISDVAFIGGSLVRHGGHNPLEAAEYSI
PLIMGPYIFNFRDICNKMYSLNGLIKITDTKSLIHIMHMLLKSKDRRLYY
GGCAFNVFKKNRGASYKILNIISHYLVKNS
>Bfl542 lepA, GTP-binding protein LepA
MKYIRNFSIIAHVNHGKSTLSDRFIQICGGLCDREMMSQVLDSMELERER
GITIKSQSVTLNYRSRSNEQFYQLNLIDTPGHVDFSYEVSRALAACEGAV
LVVDAAQGIEAQTVANYRIAMERDLKVIIALNKIDLLTADINRVSKEIEE
IIGINSNDIILCSAKTGLGVLDILERIIIDIPVPQGNCDAPLQALIIDSW
FNNYLGVISLICVKNGILHKGDTIQSMNTGQIYIVNQLGIFTPKQVQRMS
LNCGEVGWLVYTSKNHRVMGAPVGDTLTLLINPAQKSLPNFKKIQPYVYA
GLFPAGSTSQKVFADALYKLSLNDSSLHYESEYSEYLGLGFRCGFLGLLH
MEIIQERLKREYAIDLIITTPGVMYEVLVVDDQIIYVDNPLKLLSITGIK
EIREPIVLCNFLMPKKYLGEIIVLCVEKRGVQVSLVYKADQVMLTYELPM
SEIILDFFDRMKSISNGYASLEYTFNRFQASDMVCIEILINGQRVNALAV
IVHRITAEFQGRILVNKLKSLILRQQFDIVIQAVIGKRVICRDVIKQLRK
NVTHKCYGGDVTRKKKLLHNQKIGKKRMKQVGKVNLPNSVFMSILNRDS
>Bfl265 lgt, prolipoprotein diacylglyceryl transferase
MQFFYTPNFNPIILKVGCISFYWYGMMYVLSFIFAMWFLKYRKRYIVNDI
FSSTSEIENLLYLNFLGVVIGGRIGYVLFYQWSMLSQDKLWFFKLWEGGM
SFHGGLIGVIISIMWFSYCKNQSFLKISDFIVPAVPVGLGLGRLGNFING
ELWGRVTFDIPWAMLFKNALLQDLLTLKIHPEWKFFFDYYGALPRHPSQL
YEMILEGIVLFVVIYIFSCKSRPEGSISGLFLLLYGLFRIIIEFFRQPDI
HIGLINNFITLGQVLSFPMVIFGFIIMYVSYKFK
>Bfl314 lnt, apolipoprotein N-acyltransferase
MFISKAKYFFQLILSLTFGICGVFAFSPYDFWPLSIISITGLLIIILSNI
TWKQIIWNTLFWGIGFFSVGLHWIYIGIDQFIPTHKNMNFFLIAFLIIYL
TCYSVLFSIILVTLRLFITQWSFLSITAATLWLIIDRLRGNEFIGFPWLQ
FGYSQISGPIRGIGPLLGVEGITFCLVLISSLLALSIRTVQPSPYYISLI
ILACLYPLSWIQWYQVQPQRMTTIALVQGNINQHLYWNTENIQKTLKIYL
QHTLPLLGKVKIIIWPESAIPGNELAHNELLVSLDYQLRKHHTYLITGII
DSRLINNSYYHHYNSIIVLGNTHDPYKYPSSNRYDKHHLVLCSERFPLQC
LFEPVFRFFNIPIAFMKSGPYIQSQLNVYPIKMTASICYEIILGNQIRDN
FKLDSDFLLTLANDVWFGCSIGPWQHLQIARMRALELGRPILFCTNNGVT
AIINADGSIQSQLSQFISTTLITNISPTTGFTPYAQFGSWWLLIISILIC
IFIIYIQKNQLFKIFTFFKKNK
>Bfl385 lolA, outer membrane lipoprotein carrier protein precursor
MKLFIYFFCLIVFLSSSICVVHSLEPYCVLKNRLNLINNLYVHFVQKINF
CNMKEIELIRGELWIKRPNLFYCHVMGSQESFLISDGKTLWFYVPTIKQV
TAYCLENIISNNVFLQLLFMSNTNIWQDYTITQKKDWFYFKSSYDDGKHI
KQFKIKITDRGIIDQFSIIQENKQHIDYYLSNQCVNLINQDKFCFTLSDD
IQLDDQRMKF
>Bfl394 lolE, ABC transporter integral membrane subunit
MILSLRIALRFHQSFKRNTLISLISFISIIIIAIGISTAILVLSIINGFE
FELNHRILSVVPHGEITKSANISFVNWKKILNCIKKIPNIIYTNPYIRLS
GVIEYNNQWHVVYIKSIDLSNNINIYNHTLINFIEKKSWKYFCEHKNQII
LGEGVAIALNIREGDWITILFANNFHSEKRLLLLKKAYVQVSGILKLHSQ
LDNNLAIISFSDIQKYSNNKLDIDGIEFSVNNAFDIGRIIEIIKCKIREN
ENIQVHSWMDIYGYIYRDIQIVRIIIYLSMILIIAISCFSVITTLFLSIK
NKNYDIAILRVLGARDMLIQSIFLWYGFFIYCIASILGSSIGIYISMNLK
NISTRLIRFFEINISPREIYFIDFIPVQLKSIDVFIILGIVLLLGLLINW
ISLWKTKKINLSRILK
>Bfl364 lpp, major outer membrane lipoprotein
MNFRKLICFTLTISSLILIGCASTSQITELSSEIQKLNRKIDQVNENINV
LNPAIEQIKNEANRANKRLDNQISIYKK
>Bfl283 lpxA, acyl-[acyl-carrier-protein]:UDP-N- acetylglucosamine O-acyltransferase
MINRSAIVHPSSIIEEGAIIHSDVHVGPFCFIGAQVEIGARTLLKSHIVV
NGITQIGEDNQIYQFASLGEVNQDLKYAKEPTRIEIGNYNQIRESVTIHR
GTVQGGQVTKIGNSNLFMINVHIAHDCIIGNNCIMANNVTLGGHVKVDDY
TIIGGMTAVHQFCLVGSHVMIGGCSGVVQDIPPFIIAQGNHATQFGLNIE
GLKRRGFSRSAVHAIRDAYKILYRSNKTVEGAKVALKLLSTEHPIINEFV
DFLTRSQRGIIR
>Bfl284 lpxB, lipid-A-disaccharide synthase
MINNRSVIIGIVVGENSGDILGVGLIRSLKKCFKKVQFFGIGGFRMRSEN
MECWYDISELSIMGITGVIFRLPKLLNMRRELIKRFLKLKLNIFIGIDFP
DFNISLEKRLKKYGITTIHYVSPSIWAWRSNRVFALKEATHNVLLLFPFE
KSIYARCGIPNQFIGHPLADEIPLYPNKIALRQKFDIPSNRCCLAILPGS
RPKEIQILTKIFMHCAKLLQDTIPNLEILIPLHDTDLINQFVTLTSFISV
KFRVLHTLTAWEVMAAADAALLTSGTATLECMLAKCPMVVAYRMNPVIFM
LIRHLIKVKWISLPNLLAGKPIVQEFIQKKCDPQRLASSLFYLLNYNQEQ
RTTLQQEFYHLHRSIKLHANDQATRLILKYINLL
>Bfl147 lpxC, UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase
MIKQRTLKNIVCTTGIGLHTGQEVTLTLYPALANTGIIYRRIDLNPPVDF
CVNIESVGSTFLCTCLKNNTYGVQVLTVEHLSAAQSGLGIDNIIIELNGP
EVPIMDGSADPFVSLLLKAGIKELNSSKNFFRLKQIVRVEDGDRWAELRP
FNGFTLDFTIDYDHPVVNMKNKHYFFNFTSKSFRSEISSARTFGFVDNIQ
KLKNCGFVLGGSLTSSVVMDKYQVVNSEGLRFNNELVRHKILDAVGDLFM
CGYNLIGSFIGFKSGHTLNNKLLRAVLARRKAWEITSCIQGCDVSKIF
>Bfl281 lpxD, UDP-3-O-[3-hydroxymyristoyl] glucosamine N-acyltransferase
MAVKISLVDLAQNIGAELHGDKNILITHVSSIKNAQVGHITFLKNSRFRE
QLKSCAASAVILSQDNLSFCRVSALVVKNPYLAYVKVAQLLDSSPKLNAN
IKSQSVIHSNSILGKDVGIGYNVIIESGVIISDNVKIESGCIIGKNVKIG
IGTYLWSNVTVYHGVEIGEYCIIQSGSIIGSDGFGYIKNDGVWIKIPQLG
KVSIGNNVEIGSCTTIDRGTLDDTCIGDGVIIDNQCQIAHNVAIGSHTAI
AGGVIIAGSVVIGKSCMIGGASVINGHIRICDKVTITGMSMVMKSITTSG
IYSSGIPVQPNFAWRRTAALVMRIHSIDKRIKDIEQKVNCFFYIVIVGFF
IVLGLTGLFPLIYFFVKQG
>Bfl378 lpxK, tetraacyldisaccharide 4'-kinase
MLFNIWFGSSLCYLFLLPFSWVYGFFSTLNRISYKYGWRKVYRFSVPIIV
IGNLTIGGNGKTPMVLWLIDQLKTRGWRVGVVSRGYGGRSDKYPIIINST
SCSKKCGDEPLLIWRRTGVLVSVSPNRVKAVSALLKKQPLLDIIISDDGL
QHYALFRDIEWVVVHSLRRFGNGCWLPAGPMRERITRLNTVQAIIINGLS
NDIQSGAILMQLCPRSIINLVTGEIRPIQPLKDVVAIAGIGYPKQFFMTL
QDYGIFPIKTIEFSDHHMYSEIMLSSLTSGNEMLLMTEKDAIKCLDFAHE
NWWYVHIDVNIHQEDTKKLLSKIESTIQYYKNN
>Bfl119 lspA, lipoprotein signal peptidase
MYTKYKWLYLSIFFMLLDGIIKYGIRAYFQIGEVLYILPGINICYIENSG
LAFGLFSEISIHYRGIFIWLIFFIIIIFIIFLFKCRLIYEHFAYSIVIGG
SLGNLYDRIVCGKVLDYIDLYVGKYHWPVFNVADIEICVGMMILIIRGGW
NMR
>Bfl391 mltE, membrane-bound lytic murein transglycosylase E
MILTFNCIFICCNFLKIRILKDKFRYYSFIMNLYFLYIIIIIINCGGCSQ
YKKNNTNISFVDKNYDCQIKKNFSNQKRADLSTMYDIYIQRYSQMYGVDK
YLIKSIIQVESNYDSTVISKSNAIGLMQIKADTAGKDAYRLKGWEGQPST
NDLKNAVINIEIGTVYLSILQNQLKDIINVKTRRYAVIVAYVNGLGALLK
VFSEDRSRAISKINQLNPEQFYQYIKYHHPSNQAQRYLSKVNSVYMLKSA
F
>Bfl139 mraY, phospho-N-acetylmuramoyl-pentapeptidetransferase
MLFWIIKITSYFYSSTLFEVMNSVLFRGVGGLFFSLFISIVIGNRIIVWL
KYKLRMLQTIRIDGPQSHKLKYGTPTMGGIIILISVVTSVIIWSDLSNIY
IWYILFIFVMYGILGLVDDFLKIKRGDNLGLTILNKYLWQSIIAWILIVI
MFINRVNYVENQSGLEFLRNIVCKLKIWDMILAYFVIVGTSNSVNLSDGL
DGLVIVPVILVVSGLAIVTWVVGNIYITSDLYIEHVDCIKELVVVCASII
GAGLGFLWFNSYPSQIFMGDVGSLSLGGVIGLVSILLHQEYLLLIMGGIF
VIESLSVIFQVSYFKIFKKRIFKMAPIHHHFELKGYMEPKIVVRFWIVSS
ILVLLSIVIFILSKY
>Bfl154 mrcB, penicillin-binding protein 1b; peptidoglycan synthetase
MIINHVLYIMRYSIYVFIFIVLLIGVYGVILDTKIQNRINGQVWGLPTIV
YSRIVHVEPNMYCSQEDMIRLLKTLQYREVSKITRSGEFIVYDNNIDLLR
RSFDFPNIEEKEIFVSLYFNKDKLIRIYNQNTKNDFGLLRIDPKIISVQY
APQGQQRLFIPRSKFPDILIDMLLSVEDRYFYQHDGIRISAIIRACLANI
VSGHTVQGGSTITQQLVKNLFLSNTRSLWRKFNEIYMALLFEYRYSKDRI
LELYLNEIYFGQNGNDQIRGFPLASFYYFGRPVDELSLDQQAMLIGMIKG
ASLYNPWKNPKKTLDRRNLVLKLLNNVHVIDSKLYDVLISRPLAVQSKDE
VLALHPAFMQMVCEEINNISNMYSFHDLSGLRIFTTLDPIAQQLAEKAMK
IGIRRLRQRFDAVDLEGAVVIIDRFSGVVRAMVGGADPHFSGFNRALYAR
RPIGSLIKPAIYLTALNQPNKYHLNTWIADTPIHLQQSNGFVWSPRNYDR
QFRGKVMLIDAFVKSLNIPTVHLGLVLGLDTVVDFLIKLGISSNAISSFP
SILLGAISLTPMEVAQEFQTIASGGQHSTMSCIDYIVNTKNVILYQYFPK
VKRVVSPQSAYLVMYAMQQVVTKGTSYNLSLKFSSLKLAAKTGTTNDSRD
SWFVGIDGKEVVVIWVGRDNNGKTKLTGTNGALKLYSLYLDMQSNPIPLK
LTLPSNIVHIPIDYAGNILPYKVGKNSYEYILPIWRNNFSLLPYFDNKSE
VVSYNQDVLDFSEKQDCHNMEEWINSILDE
>Bfl309 mrdA, penicillin-binding protein 2
MKSNNLQVFHSCSPESLLFTKRIMISCTVIIFIISILFIQLYRIQIMHFH
MYVTRSNENRIKIIPISPKRGIIYDRNGIALALNRTVYYLEIMPKHILNL
NQTIYKLQSLLHLNNADIQYLKKYHECFSRYQLSSIKIKLTEEQHARFAV
NQFQFDHNEITIQKYQYRYYPYGSVLTHVIGYVSKINASDIKQLNKKGIL
QQYTATQDIGKLGIERYYENILHGTPGYGAVEVNNRGKIIRKLYEKQSIP
GNSIILTLDLHLQKYITKLLIGSRSSVIVIDPRNGGIRALVSHPSYDPNL
FVNGISRTEYHLLLTDDNCPLLNRATQGVYPPASTVKPYISVSALTLGII
NKNFSFFDPGWWQLPGSEKRFRDWKRWGHGELNITKALEESSDTFFYQIA
YKMGIDNLSEWMTKFGYGKYTGIDLLEELTGIMPNREWKIKKYKTPWYQG
DTISVGIGQGYWSATPVQMSKALITLINDGNVLVPHLLNSILLNEQYYIP
YTQIERNQIGDPKSNVWEIAKDGMFGAANRPNGTVKNSFSNTEYKAAVKS
GTAQLFSLRNNQTYNPNKISKYLKDHKLMTAFAPYDKPTIAVVIILENGE
GNIPIGTITRKILDFVLLQ
>Bfl295 mreC, rod shape-determining protein MreC
MSGSINKSPYLELRLFIAILMSVVILISDGKFNLFSTIKNYIENSVCWLC
HYCDRSYYIFNHVSNVIIGYKKLVSENDELRKELFYKNSELLLMNQYRQE
NIKLHSLLNSPICNNNDPKLIAKIFFIRSNPYEQHALINQGINSNIYIGQ
PVIADSGVVGQVISVNQFSSRVLLISDFKHALSVKLKRNNIRMILMGGGY
SSELYAEYPSNFIDVSVDDILLTSGLDGRFPEGYPVAKVSNIEINSEKDC
TIIQARPIVNWKDLNYVILVFK
>Bfl296 mreD, rod shape-determining protein MreD
MYNFYIYKICNIYCSFAVAIILQYVLFFSITWYLQPSWTMMLLIYWIVLI
PNKINIGTGFFLGLILDCISCSTLGIQTLSMSIISYLTIRKIYLFRHTYV
WQQSIFIVLFSFINQNIKFLIQFLMFSVSYSPKIFYNCILDGIMWPVLIF
LIHKINNSSKIC
>Bfl046 murA, UDP-N-acetylglucosamine1-carboxyvinyltransferase
MDRFHIQGPTTLKGEVVISGAKNSALPILFATLLTSEPVEIYNVPKLKDI
DTAIKLLNQLGAQVEHQNIIVFSDTSKVHACCAPYDLVKSIRASIWILGP
LVARFGYGKVWFPGGCSIGKRLVDLHIKGLKKLGAKIILGEEYVIASVNG
RLQGAHIVMDKISVGATVTIMSAATLARGITIIDNAAREPEVIDTANFLI
MLGTNIIGAGSNRIIIEGTQKLKGGRYCIIPDRIETGTFLVAAAISRSHV
ICLRSNPNILKCVLRKLRESGADINTGKDWISLNMHGRRPKAIKICTKPY
PGFPTDMQAQFTLLNVVAIGVGKVIETIFENRFMHVPELIRMGARVQILN
NTIICHGVDTLIGTRVVSTDLRASVSLVLAGCIAEGLTIIDQVNHVDRGY
DNIERKLQNMGAHIQRITDK
>Bfl183 murB, UDP-N-acetylenolpyruvoylglucosamine reductase
MKRCTKLKILNTFSVDVYAEKVIIINDEYSLLQLWKQSRDQDKFFLILGA
GSNVLFLENYKGIVLLNRIKGIFVTENKVAWYLHVGAGEEWNTLVMYTIK
RNMPGLENLVCIPGYVGAALIQNIGAYGVELSQMCEYVDVLDLNQGDKIR
LYCHECCFRYRESIFKLNLYKYAILFVGLRINKHWKPVLSYSGLTHLNLN
SITPRQIINTIIFLRYKKLPNPIIHGNVGSFFKNPVVDFKVVSFLLKKYS
NIPYYFQEDGKVKLLAGWLIENCNLKGYILGEASVYYKQALVLINTRQKA
TGTEIAALALYVYNKVVDKFNIRLKPEVRLIGSFGEINPKKLFLK
>Bfl143 murC, UDP-N-acetylmuramate:alanine ligase
MQSSYFKNGILPIINRFYTKQIHFVGIGGIGMCGLAMLLLAQGYCITGSD
IAQNDMIRSLLKLGIKIFFGHRDSNINQEINIVVISSAIDINNPEVQQAK
RLKIPVIHRVKILSELMRYKYGIAIAGTHGKTTTVSMLTNIYVEAGLDPT
FVNGGIIRSQGVSARLGYGNDFIAESDESDKSFLRLCPVVAVITNIDTDH
MNTYHQNFEYLQEVFIKFLDKLPMYGYAVVCIDDPVVRKILPRINRKIIT
YGFSKDATLCIVKYYQYREKSNFTILIKNNKELQVVLNTPGYHNALNAAA
SIAVAIEEGIRDTVILKSMSNFTGTNRRFEFLGNYPLNIINGRVGKVMVI
DDYGHHPAELRSTIIAIRTGWSDHRLVMVFQPHRFTRTHELYDNFVRVLS
TVDVLLMLDIYSAGEQPIMGINAQSLCDSILKYAKVQPIFVQNECFLLKF
LMNLLRDKDLLLIQGAGTISEIVKALFIKR
>Bfl140 murD, UDP-N-acetylmuramoyl-L-alanine:D-glutamateligase
MIRKYQKSNVVIIGFGKTGLSCLNFFLIRGVIPKIIDTRQYPSEMKNLPS
FVEYCFGRLNDFWILNANLIVVSPGVRLDHPIIIEAMKLGIEVVGDIELF
VREISAPIIAITGSNGKSTVTQLVSKMAKQAGWSVGVAGNIGVPVLSLLK
KQYELYVLEISSFQLDVTYSLRATAATILNISVDHMDRYPKGLEEYICSK
KRIYHNSYFCVVNDSDPLTKPLLNDGIYHVSFSMNSKSADYRLEYYKGNN
WIVANGEYVLSCAELKINNCMNYMNMLSALALSDIVKIPRIVSLQVLRFF
SGLSHRFQLVYKNRNVCWINDSKATNVGATKEAINNTIITLRDGNLHLLL
GGDGKLANFFELSCLIKHYAIHLYCFGKDGVCLTQSGFNDVFLSNNIIDA
MYIISRRVQRKDIVLLSPACASLDQFSSFRARGNLFTYLAQRLG
>Bfl137 murE, UDP-N-acetylmuramoylalanyl-D-glutamate--2, 6-diaminopimelate ligase
MFKLKQLHELIVPWISGINVKIPYLTGLELDSRNINFGNLFIAIQGYNTD
GRLHIDDAINNGAVAILSESYNKSTFFIKKIVNNVEVIPIIYFNQLNKCI
SNIAGRFYDHPSLCLKLIGVTGTNGKTTITHLLTNWTSLLGERSAVMGTL
GNGVLSDINPSCCTTCSAIETQKILKQFVQSGVTFVAMEISSHGLDQYRV
DSLYFDVAIFSNISNDHLDYHNNINQYRMAKWRLFNELRVKNYVINVDDC
VGYRWLLSLSNAVAVTIKNNLPRSWSGRWIALVKADYYLYGTKIVFKSSW
GNGFIHSQLLGEVNVSNILLALGALLIMGYSLKSLLYTGSKLYPVCGRLE
VLSCLNHPTVIVDYAHTPDALKKILIFAKHLCNKGRLWCIFGCGGNRDRS
KRSLMGVIANRYSDYVIITNDNPRVEDPKLIIDDIICKIRNSEKLKIIED
RVYAINMVVSKACSDDFVLILGKGHEKYQNIGLNYISHSDQDIVKSIFK
>Bfl138 murF, UDP-N-acetylmuramoylalanyl-D-glutamyl-2, 6-diaminopimelate--D-alanyl-D-alanyl ligase
MILLSVSEISLILNAKSIGMNMNVLINTISTNSNEIKKKCMFIALIGKRY
DGHDFIEQAVMAGAQAVLVNRYVSVNVPQIIVVDTYHALVKIASWLRDRV
SSKVIAITGSSGKTSVKNMTVSILKNCGTVVSTQGNQNNLIGVPITLLNL
TYQSDFAVIELGSNQLGELNKLSKIVAADVALVNNIFISHLSGFRSLKSI
QQEKGEIFSGLACNGQVVINGDSNAVFMWNSMLQLKKRWWFSIYVKKEMD
FFANNICIYPHGVRFILSSPYGVAPVFLSILGRHSVSNALAASALAFSVG
ANLSEIVYGLQNIQPLPGRLYPILLNDGKLLLLDDTYNSNVGSMIEAINV
LSVMPGYRILVISDMLELGERYVAIQYHYYIARLISESKIDQILTIGNIS
YLISKNCKEGKHFHNKNKLIRYLLNNILFQNTYISILVKGSRSFQMERIV
DIIRDQFECYSG
>Bfl142 murG, UDP-N-acetylglucosamine:N-acetylmuramyl- (pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase
MNQSVQTIMIIAGGTGGHIFPGLSVARYLMNHGYKVVWIGSKDRIESELV
PVYNIDIKYICIQGLRGKKIYQKLITLLFLIFFAMYQSFKIIRCWKPDIV
LSMGGYVSGPSSLVAWLYGIPVIIHEQNRIMGLTNRYVSRFAKKILQGFP
NTVNGAITSGNPLRYEILSIPDPVHRLEGRTGPIRVLVVGGSTGSFIFNK
VIPEVFGKLFGKLIIWHQSGKKGFNDTIQAYKKLHCNSSNYKVVPFIDNM
AHAYSWADVIISRSGALMVSEISYVGLPAIFVPFNYHKDYQQYWNAFQLV
KSGSAIIIEQERFTSDYVSIILGNWNRKVLLNMAILSKSLEMSNATQLVA
QTVMRYLNGK
>Bfl167 nlpD, lipoprotein NlpD precursor
MLDSIFIIYKAIIYIFLKLFFLVDCNFVWYDKYFINLNMVEDLSQTKQYT
QWSKKRNCFDHEYSNVNRSSYRNSIYIVKPGDTLFYIAWITGNNYLDLAK
NNSIKDINILKTGQILRVHQNVVKMSSLFFFKKKYMKNFLIFNGNSCCLK
KIYLFLKQKYGYCKDFGKFFFNTDRVKNSVIYLNKSEMTKFNSWYWPALG
QVIRTVFDSEGGNKGIDIVGIFDQPVLAATHGQVIYVGDALQGYGNLIII
KHDNNYLSAYAHNNKVFVSEKQHVNVGDQIATMGNSGTNEVKLYFEIRHK
GKSVDPLHLMPNINK
>Bfl475 omp, outer membrane protein
MKLRYFTSLVVTMVIIAISTAGAAEFYKENNNNTLRIYGNITEGQIFVEN
KTNSDNHMSMKYGLIGKTYITDKIVGFGVWEQEFNLKNTESGVNLKNIAY
PILGYIGIKLGDFGSIDYGRNYGVLYDVDSWVDLMPEFGGDMSIPDNFLT
NRASNVVTYRNINFFGLLDGFNFAVQYQGKNDGSSDTGRTVKTENGSGYG
VSASYALGNSGLSASAAYINCVRTVDQKSLDGAYTSDLAEAYSMGVKYDA
YGAYLAAVYGESYNLMPFGNFDDVLNSEIIFGFVNKARNVAIVAQYKFDC
GFSSLVSYLHSKASDVENGYGNYLKKCVTISSSYLLSKQLSATVDYRINL
LHKTDFTTVAQINTDNMIALGVSYLF
>Bfl339 pal, peptidoglycan-associated lipoprotein precursor
MKNNKLIFTSSAYLISIMYTIFFCVSCKHMINDNKSNENMYLNFVPSDNL
KDNDIPISKTNHIQNLKLKNTIYFSLDQYCVLPIFFEILDLHADFLCNNP
LYKIIIEGHTDERGTPEYNIGLGERRAYAVKKYLQSKGVLSNQIDTVSYG
KEKPIAFGQNEESYSKNRRVVLLY
>Bfl609 rfaC, lipopolysaccharide heptosyltransferase I
MNVLIIKISSMGDIIHTLPAITDASNSIPNIMFDWVIEETFSAIPRWHPS
VQQIIPIKLRTWKNNWYSLDSWKEYRSFIKKIVKKEYDVIIDAQGLLKTA
IFVTRVAKGIKHGLDSVSATELMSCWFYDHCHFVKKNQHAIERIRNLFAI
CLQYSVPLSIGKYNIKNFFNYYKNQHNIVPYIIFFCVTTCSKKQWPKLYW
YNIIQKALNLGYHIKIPFWTVSEELFVKKIKKHFNQVIILSRLTLQEIAI
QILKSTAIISVDTGLSHLAAAFDCPNLTLYGPTDPKLVGTYGGRNQLILK
SKSNDMRHLTPDFVWSTFEKNFDILK
>Bfl607 rfaD, ADP-L-Glycero-D-mannoheptose-6-epimerase
MIIVTGGAGFIGRNLIRRLNKIQRTDILVVDNLRNGKKYKNLVGLHISDY
IDKHCFIKRLLNNSNYLKNIEVIFHEGACSNTYEWNGRYLMNNNYQYSKS
LLNYSVENSIPFIYASSASVYGKNIYSSNTFDNNENPLNIYGYSKFLFDQ
YVRSVLTKVSSQVCGLRYFNVYGPYENHKGAMASIIFNIYQKIIHRKIPV
LFIGSRDFKRDFIYIDDVVNINIWMWVNKISGIFDCGTGVSESFTLLADI
VLKFLNYDSIQYVPMPYKIRQHYQTFTKANISYLRNIGYDFSFIKLSEGI
HRYLNWLIHNN
>Bfl063 rfaE, ADP-heptose synthase
MTVILPDFLKSNVLVVGDIMLDRYWYGSTNKISFESPVPVVEINNVIDIP
GGAANVAMNIASLGGRVRLIGLVGVDDAAQRLKKRLTECKIKWNFISVDT
HPTIMKLRVMSRNQQMIRLDFEKKFNNVNTDQLMNVIKVYLPQYKVLALS
DYAKGTLDCVEEIIKIARFFKIPIIIDPKGVQFSKYKGATILTPNMSEFE
AIVGFCSNEEIIIKRAKELMNEYDLLALLITRSDQGMTLLQRSLDPLYFS
AQSKEVYDVTGAGDTVVGVLSAALSLGENLEKSCFLANAAAGSVVEKSGT
STVNVAEINNVVQKYEYTKIPTGIVDRGLLKYVVSVVRGRGEKIVMTNGV
FDILHYGHISYLMDAKKLGHRLIVAVNSDKSTRRLKGKHRPINVLERRMF
VLSALSMVDWVVSFDEDNPIQLILEISPDFLVKGGDYNVNNIVGGKEVLR
QGGQVCVLKFQEDCSSSSIIDTMEINEIN
>Bfl608 rfaF, ADP-heptose; lipopolysaccharide heptosyltransferase II
MKILVVSPSWIGDTVISHSLYRLLFKKYQSQVKIDVITSIRCEPIIKRMI
EINKIFYVPYKHRVLNLTQCYKLANLLRTENYTQAIILPNSLKSALVPFL
AKIPVRTGWRGEMRYGFINDLRILNKSFFPAIIHRYSALAYNKHSIQNFS
DLPSPLPLPQLCIQKEEILNVSIKFNLHTKKKIIGLCPGSSKGLFRNWPH
YHFVNLAIRLIYYGYHIVILGSNENYLLINDFIEKSKLKKLVQYYDNLLG
CTSLDEAVLIIALCSAIVSNDSGLMHVACALHKPVVGLYGITDSCCTPPL
FYKSKIIQGNAFKNKIMFSRMKIKKSLYNYHSSLINISVNQVFEVLKELL
R
>Bfl312 rlpB, rare lipoprotein B precursor
MYIKLFIFQIKSLISLLNEFFIFSYKKILFSIIQNTYILLMITGCGYQLS
PNIFYNKLDNTANIKQLTISLHSYDPFHSITKSIKNELYLNCINVIEDND
HIPVTLDIKNIPHLDIISISTKHIIVSVFEDGTESEYQINLRVQATYSIA
NKNNQHPMIIQVYRTFIRNPEENLSNTVQENEILEDMYRDAAQKIVYQFL
TRL
>Bfl432 tonB, TonB protein
MILIVLFYKIMLQHVNFMINSNKNICLKSTVFIFFIVVSSCILHVFLIIL
LIHCIYDDSIDHISLYNTYDHVTNTFLLPTTSSIVEDKKLYDRFSSDKTQ
PLVETKQILSTPIFVNNPDIKDVNNIAHAIDFENILIDQNNIIHDVHDTD
FQCSSPITTNSINTVDIRNQRPNLIKYVYPEYPKEAKALSIEGRVVVMYD
INHIGKVEKIRIISSIPLGIFEKNIKIAMRRWIYAVDNAKKDLIIIFKFS
LNTIQFLEN
>Bfl134 yabC, putative S-adenosyl methionine adenyltransferase
MFIMHHNSVLLHEAINALNINPSGIYIDGTFGLGGHSHYILSKLTSHGRL
IAMDRDWSAVNIGEVLTKQDGRFSIIHAPFSKMLRCIYNMNLVGLINGIL
LDLGVCESQLTDSSRGFSFMRDGPLDMRMDNSVGQSAYEWIAKASQKDIE
WVLRTFGEEKLSKKIARSIVLKREVYPIDRTSALSEIISDTVLYYNNRYN
RRKHPATRSFLAIRIYINEELVEIMKILQDVFKLLAPGGRLVVISFNSLE
DRIVKKFINQYSRVFAYPPKIPLTHTQLLHKYSGTMKFKNLGKIKPTVLE
IKKNIRARSAILRYAEKLIYM
>Bfl278 yaeL, putative membrane-associated Zn-dependent protease
MVLDYFWNIVFFILTISLLITVHECGHFLAARFFGVKVEKFSIGFGPIVW
SWQANKDSTEYIISIIPLGGYVKLLDKSSISSDSESYHTRNDSFHSKDSW
KRGIIIAMGPIFNIIFSIILYTLVFMIGVPVYKPIINYIFPNSIVEKINI
PVGSEIKSINGIKTVDWESVRLNILHNINKEKIVISTICVNNDEIYEKSY
VIPLSINWLDKSIIKTQDPIIALGVLPCIFRATLNASEIKLHPVSEQDTL
QINDKILLINKLPIYNWQSLIQIVKNNSGQSCQLVVERDKHLLYLNVVLI
DNYEVDSGKFLKNINFFLAPDIVCKSIKPVIRTDELFTAILKACNKTIDL
FIFTVNALFQLVSGNVRITNLHGPIAIAQGAGKSIHSGINYYLMFLAVVS
INLGLINLFPIPILDGGQLCFLLIEKIKGSPLSKKIQNFSYIISFAILIL
IMVLTTYNDITR
>Bfl279 yaeT, outer membrane protein precursor
MHSIGDIINNIIKKLIIMFLFIISNVTYGDDFIVKKIFFHGLHRMSSDAI
LYQLPLKVGTTISNKNVSDSIRFLFSTGYFSNVSVFNDENGIIVIKVEEY
PIIHSIEFSGNKIIKTEMIQSILNSKNIKIGSTLNDYFIFEANNDIQDIY
HNFGKFNVSVKINTIVLPKNRVIVKITVYEGKTANVKQIKIFGNYIFSQK
KLLKQFSIYKQIKWNNIFHRNVYKKQKFFYDLESLRVFYLSNGYAKFCID
ETDIKMTPDKRNVYLNIYITEGLQYILESVSIHGDVLCCVPSIKDYCQTF
STELYDINKINKIEHDIRLLLGRYGYIKPAMSIEYDFNDHKKVVKLHIYI
DVGHRFYVREVQFEGNNFTQDFVIRREIKQLEQSLLNYHYVLQDQERLSR
LNYFKLVNTRIENVPNKSNQVDLIYKIEELNTTGNLNLSVGLGTESGLNI
QIGMNQDNVLGTGNSISVTATKNYYQTYCDMSILKKYLGTRRINTSIQIF
YNNFSTNKVHLSNYSIKNYGISMDFAYPVTENNSYNIGLNYISNHLDQIE
PQIAVWRYLYSVGINPELISNYQYLNNRINLYPRDLLLVLGWSFNSLNHM
YFPNFGSFINITNKLTLPGSYNSYYKIILDSNHYLPLNKSLDWILFSSIY
AGYAGSLYNHKESPFYDNFYIGGIRTIRGFRLNSIGPKAAYYHCNKSDIS
YSTCSVKNSQDTVGGNSVTFIKNELIIPVSYMLNTQYSDTTRVSLFIDAG
TVWDTYWINTVATRAAGILDYGIFGHIRISTGVALKWISPVGPVIFSYSK
PIKKYQGDIEEPFQFTVGKIW
>Bfl396 ycfU, ABC transporter integral membrane subunit
MHMLLVVLFVASRYIYGKTVNRLNQCIYWVSSIFIMLSMSAMIIILSVMN
GFESELKKNLLYLIPHVVVTSTQGYINSKNIPDFLSLPAIKNNITYIKPL
IFSDIILQSSKSISLGMMFGVDPNHFEPLFDYLIHHNVSQLISGKYYIII
GSALAQKLSVNIHDQIRLTVPSIHYNTPIGCFPIQRLFTILDIYHSSNDE
IDSCQVLVHKNDAAVLLNYPPQNITGWRIWIDEPFKVSKLEQWQCPKDWI
WTDWRKYKGSLFQAIKMEKNVMFFLFILMIVTVSGNIIAFLVLLITEKHK
EIAILQTYGFNRLQIVILLIIQGVSSGVLGIICGVGLGVCLAKKLNQILF
LLNIFSENLYFPIEIPFIQIFNISLMICGFIVLIILYPAWYISSIYPAQV
LRHGQ
>Bfl451 yebA, conserved hypothetical protein
MIKFVMSVCIPVFRSIKLIYHYLYKRCFMMLSTIFLIIIIMIIWNIFVIN
VLNKNKKKINKICISNEYTTLSQSLVSVHNNQYYNKSVDYLKFVKNQFYS
AQSVGFFVIYDYFVSSSNDALIDILKCYNDKIIIDIDCIYQLINQYPILN
NLKSGQLLSWVVSNKKQLQSLIWCISDHEIHIYNNMKTFFTQGIVKVFKR
SNNRSFYTVLFVGKVNGTFINSARSLGIEKNCISDVIKSLQYQLDFKKLR
QGDKFAILVSFEDNDSDNLKIKLIGARLHTAGKDYYVFRASNGRFYNRDA
IEVGSNFFRFPILKPYRISSNFNLNRLNPITGQVTQHTGVDFAVPIGTPV
FSIGDGEVIISKYSKVAGNYVVIKHNHQCITRYMHLQKLLVKSGQKIKRG
DSIAFSGNTGRSTGPHLHFEIWINHRPVNPLTANLLSIEKLSGKERIKYL
NQIHEIIPQLYFD
>Bfl073 yjeP, putative membrane protein
MIHTSKTFQIIFYFITTYIFTYLIPSNAFSYHYFHETHTIQKLQHVIKKP
THAKINQKSITKFLLPTSYNQIKNQNINFHTTHKYKKIINNFSSYIIFHL
QKKYKETNNYIIFIYQTWTKQQLQEKSIIYIHTFLIKYLTYTIAQPTQQY
INILKTTTLHYNILKNFNQNNTSFTWHRKLLNNKYNDTYHSLQTLNNQSY
YPNNHKKKHITHPIKTVCIKHNNDTLPKSIKNQLYINHELSLIINQQIHD
MNNIISKQKEITAHILQVNQTFSNLIEQSQWINKSPALGETLRSQVSELP
KIPKFQQLDNDMAQLRAKRLQYANQINKISTLLSYSKQDDGSNLTTFQKN
ILEKQLNIQHTLIISLLNNYDKQILELTKLKLFYEQLKHALQKIQQATHR
YLFWVADIYPITISYPIDIYRDILKLIINKSFHYQIKSAFHMILTHKKTL
ILTILCIITSLSLHFGIRHHYYEFLERTSEYIGKVNQDNFRITFYNISSS
IFMALPIPILWVCIGYNLNHAWPYPIIVAIGDGMNSTVYILWAFIISGYF
ASPHGLFITHFGWPKKRIQQVFSKHYPWSVTIIISLITTLITINNYNNRE
FSNTLGRLCFLILCIYLTFITNTLKHSGLPLYLNKYDSTDNIVNRSLWNI
MICAPIIAAISCFFGYLFAAQILLIRLEASLFIWILLLIIYHIIRRWMFI
QRRRIALERAKKKRATQLILRSKNQPDLSYKLSHKEQFTISHDNNKKSLD
LDTISAQSLQLIRSIITLVAVLFMILLWSELRFAFSFLENITLWDVTSTI
KGIDNIRPITLNAFLTVIVVIIITTITVRNLPSFLELTLLQYLNLNPGTE
YAVIALTKYIIMLLGSLIGLSLIGIEWVKIQWLIAALGVGLGFGLQEIFA
NFISGLIILFEKPIRIGDTITIKNFTGSITRINTRATIITDWDHKEIIVP
NKEFITKQFTNWSLSDTTTRITLRIPAPLKIDSKEITNVFTKIIKSSPLV
LKTPPPEVYLIDLQYGFPIFEIRLYTINLKSRVPLRHQINIKILEYYKHN
NIELPNIPFYFYKNLSIDPAIHSHSVFFDTTKPIF